Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 25% ± 7% | |
pericyte | 7 studies | 24% ± 13% | |
smooth muscle cell | 6 studies | 20% ± 2% | |
fibroblast | 6 studies | 25% ± 8% | |
B cell | 5 studies | 19% ± 3% | |
natural killer cell | 4 studies | 19% ± 2% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 19% ± 3% | |
epithelial cell | 4 studies | 35% ± 17% | |
CD8-positive, alpha-beta memory T cell | 4 studies | 18% ± 1% | |
CD4-positive, alpha-beta T cell | 3 studies | 20% ± 3% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 21% ± 4% | |
connective tissue cell | 3 studies | 17% ± 1% | |
pro-B cell | 3 studies | 23% ± 3% | |
naive B cell | 3 studies | 17% ± 0% | |
regulatory T cell | 3 studies | 17% ± 1% | |
GABAergic neuron | 3 studies | 21% ± 3% | |
glutamatergic neuron | 3 studies | 27% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1921.79 | 180 / 180 | 100% | 19.07 | 430 / 430 |
lung | 100% | 1301.11 | 578 / 578 | 100% | 20.80 | 1153 / 1155 |
brain | 100% | 1027.22 | 2634 / 2642 | 100% | 22.58 | 705 / 705 |
breast | 100% | 1435.27 | 459 / 459 | 100% | 27.04 | 1113 / 1118 |
thymus | 100% | 1533.23 | 653 / 653 | 100% | 26.51 | 602 / 605 |
esophagus | 100% | 1323.19 | 1445 / 1445 | 99% | 25.71 | 182 / 183 |
prostate | 100% | 1483.86 | 245 / 245 | 99% | 22.53 | 499 / 502 |
uterus | 100% | 1537.29 | 170 / 170 | 99% | 21.20 | 453 / 459 |
intestine | 100% | 1415.73 | 966 / 966 | 99% | 18.29 | 520 / 527 |
stomach | 100% | 1075.21 | 359 / 359 | 98% | 19.84 | 281 / 286 |
bladder | 100% | 1265.57 | 21 / 21 | 98% | 16.79 | 495 / 504 |
adrenal gland | 100% | 1452.64 | 258 / 258 | 98% | 16.07 | 225 / 230 |
kidney | 100% | 1043.24 | 89 / 89 | 97% | 17.53 | 873 / 901 |
pancreas | 99% | 693.16 | 325 / 328 | 98% | 16.44 | 174 / 178 |
liver | 100% | 976.19 | 226 / 226 | 92% | 11.34 | 375 / 406 |
skin | 100% | 1481.14 | 1808 / 1809 | 92% | 17.37 | 435 / 472 |
adipose | 100% | 1472.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1350.79 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1366.61 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.36 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.92 | 1 / 1 |
muscle | 100% | 789.41 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 674.86 | 846 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 16.33 | 28 / 29 |
peripheral blood | 86% | 943.56 | 801 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 73% | 8.66 | 58 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016925 | Biological process | protein sumoylation |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0051443 | Biological process | positive regulation of ubiquitin-protein transferase activity |
GO_0006974 | Biological process | DNA damage response |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0042771 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO_0051457 | Biological process | maintenance of protein location in nucleus |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0034504 | Biological process | protein localization to nucleus |
GO_0008630 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage |
GO_0006513 | Biological process | protein monoubiquitination |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0030496 | Cellular component | midbody |
GO_0032391 | Cellular component | photoreceptor connecting cilium |
GO_0000922 | Cellular component | spindle pole |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005814 | Cellular component | centriole |
GO_0000930 | Cellular component | gamma-tubulin complex |
GO_0016605 | Cellular component | PML body |
GO_0036064 | Cellular component | ciliary basal body |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0019789 | Molecular function | SUMO transferase activity |
GO_0044547 | Molecular function | DNA topoisomerase binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003823 | Molecular function | antigen binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TOPORS |
Protein name | E3 ubiquitin-protein ligase Topors (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Topors) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (Tumor suppressor p53-binding protein 3) (p53-binding protein 3) (p53BP3) |
Synonyms | LUN TP53BPL |
Description | FUNCTION: Functions as an E3 ubiquitin-protein ligase and as an E3 SUMO1-protein ligase. Probable tumor suppressor involved in cell growth, cell proliferation and apoptosis that regulates p53/TP53 stability through ubiquitin-dependent degradation. May regulate chromatin modification through sumoylation of several chromatin modification-associated proteins. May be involved in DNA damage-induced cell death through IKBKE sumoylation. . |
Accessions | Q9NS56 ENST00000379858.1 [Q9NS56-2] ENST00000360538.7 [Q9NS56-1] |